Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,097
Closed -$27.8K 1123
2025
Q1
$27.8K Sell
3,097
-46,371
-94% -$491K ﹤0.01% 1051
2024
Q4
$480K Buy
+49,468
New +$530K ﹤0.01% 949
2013
Q4
Sell
-5,370
Closed -$679K 1383
2013
Q3
$679K Buy
5,370
+1,085
+25% +$130K ﹤0.01% 942
2013
Q2
$497K Buy
+4,285
New +$591K ﹤0.01% 967

Other funds holding AMRN

Axa's AMRN Position: Q2 2025 in Review

Axa sold out of Amarin Corp (AMRN) in Q2 2025, closing a stake of 3,097 shares — an estimated $27.8K sold.

Axa first reported a position in AMRN in Q2 2013 and held it in 4 quarters. The position peaked at $679K in Q3 2013. 89 funds tracked by Wall St. Rank hold AMRN as of Q2 2025.

  • Axa reported no remaining Amarin Corp position as of Q2 2025 after selling out during the quarter.
  • Axa sold 3,097 Amarin Corp shares in Q2 2025, an estimated $27.8K.
  • Axa first reported a position in Amarin Corp in Q2 2013 and held it in 4 quarters.
  • Axa's Amarin Corp position peaked at $679K in Q3 2013.
  • 89 funds tracked by Wall St. Rank held Amarin Corp as of Q2 2025.

Based on Axa's 13F filing for Q2 2025, filed 14 Aug 2025.